RH
Distinguished in Micrognathia
Check Dr. Robert J. Hopkin's experience treating your condition:
About Dr. Robert J. Hopkin

Robert Hopkin is a Pediatrics specialist and a Medical Genetics expert in Cincinnati, Ohio. Hopkin has been practicing medicine for over 33 years and is rated as a Distinguished expert by MediFind in the treatment of Micrognathia. He is also highly rated in 116 other conditions, according to our data. His top areas of expertise are Fabry Disease, Ohdo Syndrome, Say-Barber-Biesecker-Young-Simpson Variant, Neurofibromatosis Type 1 (NF1), and Micrognathia. He is licensed to treat patients in Ohio. Hopkin is currently accepting new patients.

His clinical research consists of co-authoring 124 peer reviewed articles and participating in 4 clinical trials in the past 15 years. In particular, he has co-authored 5 articles in the study of Micrognathia.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Robert J. Hopkin it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
Locations
3333 Burnet Ave, Cincinnati, OH 45229
Other Locations
7777 Yankee Rd, Liberty Township, OH 45044
Background & Education
Graduate Institution
University Of Nevada School Of Medicine, 1990
Specialties
Pediatrics
Medical Genetics
Licenses
Clinical Genetics in OH
Hospital Affiliations
Cincinnati Childrens Burnet Campus
University Of Cincinnati Medical Center
Languages Spoken
English
French
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


4 Clinical Trials

A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of RAD011 (Cannabidiol Oral Solution) for the Treatment of Patients With Prader- Willi Syndrome
A Randomized, Double Blind, Active Control Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function in Patients With Fabry Disease Previously Treated With Agalsidase Beta
View 3 Less Clinical Trials -

124 Total Publications

Arrhythmia Burden and Heart Rate Response During Exercise in Anderson-Fabry Disease.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Distinguished
Advanced
Advanced